UBS AM’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.1K Sell
519
-13,634
-96% -$737K ﹤0.01% 3033
2026
Q1
$767K Buy
14,153
+365
+3% +$24K ﹤0.01% 2432
2025
Q4
$847K Buy
13,788
+154
+1% +$9.94K ﹤0.01% 2194
2025
Q3
$996K Sell
13,634
-11,811
-46% -$931K ﹤0.01% 2012
2025
Q2
$1.89M Buy
25,445
+7,032
+38% +$492K ﹤0.01% 2171
2025
Q1
$1.38M Sell
18,413
-292
-2% -$27.1K ﹤0.01% 2172
2024
Q4
$1.91M Buy
18,705
+4,525
+32% +$519K ﹤0.01% 2067
2024
Q3
$1.49M Sell
14,180
-1,293
-8% -$132K ﹤0.01% 2188
2024
Q2
$1.44M Buy
15,473
+9,286
+150% +$985K ﹤0.01% 2170
2024
Q1
$806K Hold
6,187
﹤0.01% 2112
2023
Q4
$701K Buy
6,187
+3,434
+125% +$298K ﹤0.01% 2206
2023
Q3
$226K Sell
2,753
-1,783
-39% -$157K ﹤0.01% 2491
2023
Q2
$308K Hold
4,536
﹤0.01% 2470
2023
Q1
$308K Sell
4,536
-3,383
-43% -$274K ﹤0.01% 2470
2022
Q4
$563K Hold
7,919
﹤0.01% 2135
2022
Q3
$492K Buy
7,919
+1,395
+21% +$101K ﹤0.01% 2351
2022
Q2
$436K Buy
+6,524
New +$490K ﹤0.01% 2357

Other funds holding BXC

UBS AM's BXC Position: Q2 2026 in Review

UBS AM reduced its BlueLinx (BXC) stake by 96% in Q2 2026, selling an estimated $737K and leaving 519 shares worth $32.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3033.

UBS AM first reported a position in BXC in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.91M in Q4 2024. 158 funds tracked by Wall St. Rank hold BXC as of Q2 2026.

  • UBS AM held 519 shares of BlueLinx worth $32.1K as of Q2 2026.
  • UBS AM sold 13,634 BlueLinx shares in Q2 2026, an estimated $737K.
  • BlueLinx made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3033 holding.
  • UBS AM first reported a position in BlueLinx in Q2 2022 and has held it in 17 quarters since.
  • UBS AM's BlueLinx position peaked at $1.91M in Q4 2024.
  • 158 funds tracked by Wall St. Rank held BlueLinx as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.